| 000 | 01915 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514203752.0 | ||
| 264 | 0 | _c20050111 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-04-0652 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Jie | |
| 245 | 0 | 0 |
_aValue of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cSep 2004 |
||
| 300 |
_a6119-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCholecystitis _xdiagnosis |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p16 _xbiosynthesis |
| 650 | 0 | 4 | _aDNA Methylation |
| 650 | 0 | 4 |
_aDNA Restriction Enzymes _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGallbladder Neoplasms _xpathology |
| 650 | 0 | 4 | _aGene Silencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 | _aStatistics as Topic |
| 650 | 0 | 4 |
_aSulfites _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 700 | 1 | _aLee, J Jack | |
| 700 | 1 | _aWang, Luo | |
| 700 | 1 | _aLiu, Diane D | |
| 700 | 1 | _aLu, Charles | |
| 700 | 1 | _aFan, You-Hong | |
| 700 | 1 | _aHong, Waun Ki | |
| 700 | 1 | _aMao, Li | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 10 _gno. 18 Pt 1 _gp. 6119-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-04-0652 _zAvailable from publisher's website |
| 999 |
_c15140627 _d15140627 |
||